• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醛固酮过多与难治性高血压患者呼吸暂停低通气指数的关系。

Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension.

机构信息

Department of Cardiology, Shenzhen Sun Yat-sen Cardiovascular Hospital, Shenzhen, China.

Department of Cardiology, the Fifth subsidiary Sun Yat-sen University Hospital, Zhuhai, China.

出版信息

Sci Rep. 2017 Mar 22;7:45241. doi: 10.1038/srep45241.

DOI:10.1038/srep45241
PMID:28327653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5361120/
Abstract

The present study was to investigate the association of aldosterone excess and apnea-hypopnea index (AHI) in patients with resistant hypertension. Patients with resistant hypertension were enrolled and baseline characteristics including plasma aldosterone concentration (PAC) and 24 h-urine aldosterone levels were collected and compared between groups with different degrees of AHI as assessed by polysomnography. Association of key variables and AHI was then evaluated by univariate and multiple linear regression analysis. A total of 534 patients with resistant hypertension were enrolled and mean age was 57 ± 11 years. Overall, mean number of AHI was 21.7 ± 9.6 and nearly 92.3% of resistant hypertensive patients had obstructive sleep apnea (OSA). Mean PAC and 24 h-urine aldosterone level was 12.4 ± 6.3 ng/dL and 13.1 ± 6.8 ug, respectively. Compared with other groups, participants in the severe OSA group (AHI ≥ 30) had significantly higher PAC and 24 h-urine aldosterone level. Multiple linear regression analysis showed that PAC and 24 h-urine aldosterone levels were positively associated with AHI, while spironolactone was negatively associated with AHI, independent of age, gender, body mass index, smoking, plasma renin activity and diuretics. OSA is highly prevalent in patients with resistant hypertension and both PAC and 24 h-urine aldosterone level are significantly associated with AHI.

摘要

本研究旨在探讨醛固酮过多与难治性高血压患者呼吸暂停低通气指数(AHI)的关系。纳入难治性高血压患者,收集其基线特征,包括血浆醛固酮浓度(PAC)和 24 小时尿醛固酮水平,并根据多导睡眠图评估的不同 AHI 程度进行组间比较。然后通过单因素和多元线性回归分析评估关键变量与 AHI 的相关性。共纳入 534 例难治性高血压患者,平均年龄为 57±11 岁。总体而言,AHI 的平均值为 21.7±9.6,近 92.3%的难治性高血压患者患有阻塞性睡眠呼吸暂停(OSA)。平均 PAC 和 24 小时尿醛固酮水平分别为 12.4±6.3ng/dL 和 13.1±6.8μg。与其他组相比,严重 OSA 组(AHI≥30)的 PAC 和 24 小时尿醛固酮水平显著升高。多元线性回归分析显示,PAC 和 24 小时尿醛固酮水平与 AHI 呈正相关,而螺内酯与 AHI 呈负相关,与年龄、性别、体重指数、吸烟、血浆肾素活性和利尿剂无关。OSA 在难治性高血压患者中非常普遍,PAC 和 24 小时尿醛固酮水平与 AHI 显著相关。

相似文献

1
Association of aldosterone excess and apnea-hypopnea index in patients with resistant hypertension.醛固酮过多与难治性高血压患者呼吸暂停低通气指数的关系。
Sci Rep. 2017 Mar 22;7:45241. doi: 10.1038/srep45241.
2
Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.血浆醛固酮与顽固性高血压患者阻塞性睡眠呼吸暂停的严重程度相关。
Chest. 2007 Feb;131(2):453-9. doi: 10.1378/chest.06-1442.
3
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.阻塞性睡眠呼吸暂停的严重程度与难治性高血压患者的醛固酮状态有关。
J Clin Sleep Med. 2010 Aug 15;6(4):363-8.
4
Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial.持续气道正压通气治疗对阻塞性睡眠呼吸暂停合并顽固性高血压患者醛固酮排泄的影响:一项随机对照试验。
J Hypertens. 2017 Apr;35(4):837-844. doi: 10.1097/HJH.0000000000001254.
5
Association of objective and subjective parameters of obstructive sleep apnea with plasma aldosterone concentration in 2,066 hypertensive and 25,368 general population.2066 例高血压患者和 25368 例普通人群中阻塞性睡眠呼吸暂停的客观和主观参数与血浆醛固酮浓度的关系。
Front Endocrinol (Lausanne). 2023 Jan 16;13:1016804. doi: 10.3389/fendo.2022.1016804. eCollection 2022.
6
A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea.持续气道正压通气对顽固性高血压合并阻塞性睡眠呼吸暂停患者血浆醛固酮浓度影响的随机对照研究
J Hypertens. 2014 Aug;32(8):1650-7; discussion 1657. doi: 10.1097/HJH.0000000000000238.
7
Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension.顽固性高血压患者阻塞性睡眠呼吸暂停的患病率及相关因素
Am J Hypertens. 2014 Aug;27(8):1069-78. doi: 10.1093/ajh/hpu023. Epub 2014 Apr 4.
8
Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.顽固性高血压且有睡眠呼吸暂停症状的受试者的醛固酮排泄情况。
Chest. 2004 Jan;125(1):112-7. doi: 10.1378/chest.125.1.112.
9
Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study.原发性高血压患者中阻塞性睡眠呼吸暂停与尿白蛋白排泄的相关性:一项横断面研究
Am J Kidney Dis. 2008 Aug;52(2):285-93. doi: 10.1053/j.ajkd.2008.05.001. Epub 2008 Jul 9.
10
Craniofacial abnormalities in Chinese patients with obstructive and positional sleep apnea.中国阻塞性和体位性睡眠呼吸暂停患者的颅面异常。
Sleep Med. 2008 May;9(4):403-10. doi: 10.1016/j.sleep.2007.04.024. Epub 2007 Jul 19.

引用本文的文献

1
Obstructive sleep apnea-associated hypertensive disorders in pregnancy: a literature review and clinical management strategies.妊娠合并阻塞性睡眠呼吸暂停相关高血压疾病:文献综述与临床管理策略
Reprod Biol Endocrinol. 2025 Aug 2;23(1):114. doi: 10.1186/s12958-025-01431-x.
2
Mineralocorticoid receptor antagonists in adults with resistant hypertension and obstructive sleep apnoea.盐皮质激素受体拮抗剂用于患有顽固性高血压和阻塞性睡眠呼吸暂停的成年人。
Aust Prescr. 2024 Aug;47(4):129-130. doi: 10.18773/austprescr.2024.033.
3
Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society.抗药性高血压:泰国高血压学会的临床共识声明中的诊断、评估和治疗。
Hypertens Res. 2024 Sep;47(9):2447-2455. doi: 10.1038/s41440-024-01785-6. Epub 2024 Jul 16.
4
Association of objective and subjective parameters of obstructive sleep apnea with plasma aldosterone concentration in 2,066 hypertensive and 25,368 general population.2066 例高血压患者和 25368 例普通人群中阻塞性睡眠呼吸暂停的客观和主观参数与血浆醛固酮浓度的关系。
Front Endocrinol (Lausanne). 2023 Jan 16;13:1016804. doi: 10.3389/fendo.2022.1016804. eCollection 2022.
5
Influence and implications of the renin-angiotensin-aldosterone system in obstructive sleep apnea: An updated systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统在阻塞性睡眠呼吸暂停中的影响及意义:一项更新的系统评价和荟萃分析。
J Sleep Res. 2023 Feb;32(1):e13726. doi: 10.1111/jsr.13726. Epub 2022 Sep 14.
6
The Role of Aldosterone in OSA and OSA-Related Hypertension.醛固酮在阻塞性睡眠呼吸暂停(OSA)及 OSA 相关高血压中的作用。
Front Endocrinol (Lausanne). 2022 Jan 12;12:801689. doi: 10.3389/fendo.2021.801689. eCollection 2021.
7
Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease.阻塞性睡眠呼吸暂停、高血压、顽固性高血压与心血管疾病。
Sleep Med Disord. 2020;4(3):67-76. Epub 2020 Nov 23.
8
Obstructive Sleep Apnea as a Risk Factor of Insulin Resistance in Nondiabetic Adults.阻塞性睡眠呼吸暂停作为非糖尿病成年人胰岛素抵抗的一个危险因素。
Life (Basel). 2021 Jan 13;11(1):50. doi: 10.3390/life11010050.
9
Long-Term Effects of Continuous Positive Airway Pressure (CPAP) Therapy on Obesity and Cardiovascular Comorbidities in Patients with Obstructive Sleep Apnea and Resistant Hypertension-An Observational Study.持续气道正压通气(CPAP)治疗对阻塞性睡眠呼吸暂停合并顽固性高血压患者肥胖及心血管合并症的长期影响——一项观察性研究
J Clin Med. 2020 Aug 30;9(9):2802. doi: 10.3390/jcm9092802.
10
Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea-what do we know so far?原发性醛固酮增多症与糖尿病、骨骼健康不良和睡眠呼吸暂停之间的关联:我们目前了解多少?
J Hum Hypertens. 2020 Jan;34(1):5-15. doi: 10.1038/s41371-019-0294-8. Epub 2019 Dec 10.

本文引用的文献

1
Trends in Antihypertensive Medication Use Among US Patients With Resistant Hypertension, 2008 to 2014.2008年至2014年美国顽固性高血压患者的抗高血压药物使用趋势
Hypertension. 2016 Dec;68(6):1349-1354. doi: 10.1161/HYPERTENSIONAHA.116.08128. Epub 2016 Oct 24.
2
Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.体重指数可预测顽固性高血压患者的24小时尿醛固酮水平。
Hypertension. 2016 Oct;68(4):995-1003. doi: 10.1161/HYPERTENSIONAHA.116.07806. Epub 2016 Aug 15.
3
Hypertension and obstructive sleep apnea.高血压与阻塞性睡眠呼吸暂停。
Hypertens Res. 2016 Jun;39(6):391-5. doi: 10.1038/hr.2016.11. Epub 2016 Feb 18.
4
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.降压预防心血管疾病和死亡:系统评价和荟萃分析。
Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24.
5
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.强化降压对心血管和肾脏结局的影响:更新的系统评价和荟萃分析。
Lancet. 2016 Jan 30;387(10017):435-43. doi: 10.1016/S0140-6736(15)00805-3. Epub 2015 Nov 7.
6
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.螺内酯与安慰剂、比索洛尔及多沙唑嗪对比以确定难治性高血压的最佳治疗方案(PATHWAY-2):一项随机、双盲、交叉试验
Lancet. 2015 Nov 21;386(10008):2059-2068. doi: 10.1016/S0140-6736(15)00257-3. Epub 2015 Sep 20.
7
Relationship Between OSA and Hypertension.阻塞性睡眠呼吸暂停与高血压之间的关系。
Chest. 2015 Sep;148(3):824-832. doi: 10.1378/chest.15-0136.
8
Sleep apnea and cardiovascular disease: a bidirectional relationship.睡眠呼吸暂停与心血管疾病:一种双向关系。
Circulation. 2012 Sep 18;126(12):1495-510. doi: 10.1161/CIRCULATIONAHA.111.070813.
9
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.强化降压对心血管和肾脏结局的影响:系统评价和荟萃分析。
PLoS Med. 2012;9(8):e1001293. doi: 10.1371/journal.pmed.1001293. Epub 2012 Aug 21.
10
Differing relationship of nocturnal fluid shifts to sleep apnea in men and women with heart failure.男性和女性心力衰竭患者夜间液体转移与睡眠呼吸暂停的关系不同。
Circ Heart Fail. 2012 Jul 1;5(4):467-74. doi: 10.1161/CIRCHEARTFAILURE.111.965814. Epub 2012 Jun 7.